SE7500172L - - Google Patents

Info

Publication number
SE7500172L
SE7500172L SE7500172A SE7500172A SE7500172L SE 7500172 L SE7500172 L SE 7500172L SE 7500172 A SE7500172 A SE 7500172A SE 7500172 A SE7500172 A SE 7500172A SE 7500172 L SE7500172 L SE 7500172L
Authority
SE
Sweden
Application number
SE7500172A
Inventor
W H Holleman
W W Andres
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of SE7500172L publication Critical patent/SE7500172L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3153—Streptokinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y10S435/816—Enzyme separation or purification by solubility

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
SE7500172A 1974-01-11 1975-01-08 SE7500172L (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US432789A US3865692A (en) 1974-01-11 1974-01-11 Method for making highly potent plasminogen

Publications (1)

Publication Number Publication Date
SE7500172L true SE7500172L (enExample) 1975-07-14

Family

ID=23717599

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7500172A SE7500172L (enExample) 1974-01-11 1975-01-08

Country Status (7)

Country Link
US (1) US3865692A (enExample)
JP (1) JPS5314603B2 (enExample)
CA (1) CA1017696A (enExample)
DE (1) DE2500810A1 (enExample)
FR (1) FR2258393B1 (enExample)
GB (1) GB1473245A (enExample)
SE (1) SE7500172L (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082612A (en) * 1976-09-24 1978-04-04 Michael Reese Research Foundation Plasminogen activator complex
US4245051A (en) * 1978-03-30 1981-01-13 Rockefeller University Human serum plasminogen activator
JPS56106594A (en) * 1980-01-25 1981-08-24 Green Cross Corp:The Stabilizing method of plasminogen
JPS5716824A (en) * 1980-07-03 1982-01-28 Green Cross Corp:The Plasminogen pharmaceutical and stabilizing method thereof
GB2068002B (en) * 1980-01-25 1983-06-29 Green Cross Corp Plasminogen preparation and their production
EP0156169B1 (en) * 1984-02-29 1991-12-18 Asahi Kasei Kogyo Kabushiki Kaisha An aqueous solution of a tissue plasminogen activator dissolved therein at an increased concentration and a method
US4774087A (en) * 1987-08-14 1988-09-27 Northwestern University Micro-size fibrinolytic plasmin
US5928772A (en) * 1996-06-13 1999-07-27 Dainippon Ink And Chemicals, Inc. Panel material and method of manufacturing the same
US6355243B1 (en) * 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
UA103771C2 (ru) * 2008-06-04 2013-11-25 Грифолз Терапьютикс Инк. Стрептокиназа, активирующая плазмин, способ и набор для получения плазмина
JP5789521B2 (ja) * 2009-03-03 2015-10-07 グリフオルス・セラピユーテイクス・インコーポレーテツドＧｒｉｆｏｌｓ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． プラスミノーゲンを製造するための組成物、方法およびキット；ならびにそれから製造されるプラスミン

Also Published As

Publication number Publication date
DE2500810A1 (de) 1975-07-17
JPS5314603B2 (enExample) 1978-05-18
FR2258393B1 (enExample) 1978-06-23
JPS50100213A (enExample) 1975-08-08
GB1473245A (en) 1977-05-11
CA1017696A (en) 1977-09-20
FR2258393A1 (enExample) 1975-08-18
US3865692A (en) 1975-02-11
AU7680974A (en) 1976-06-24

Similar Documents

Publication Publication Date Title
DK51175A (enExample)
FR2258393B1 (enExample)
FR2263220A1 (enExample)
DK139193C (enExample)
CS166545B1 (enExample)
CU34062A (enExample)
CH582614A5 (enExample)
CH579829A5 (enExample)
CH578561A5 (enExample)
CH593119A5 (enExample)
CH589960A5 (enExample)
DD121466A3 (enExample)
CH586443A5 (enExample)
CH591822A5 (enExample)
CH593509B5 (enExample)
CH579790B5 (enExample)
CH597945A5 (enExample)
CH1434174A4 (enExample)
CH599568A5 (enExample)
CH597141A5 (enExample)
CH586358A5 (enExample)
CH597161A5 (enExample)
CH600056A5 (enExample)
BG20724A1 (enExample)
CH577863A5 (enExample)